Comparative Outcomes of MOSES <b>™</b> 1.0 Versus 2.0 in Holmium Laser Enucleation of the Prostate Is There Really a Difference?

Compared with the 1.0, the MOSES™ 2.0 laser demonstrated significantly improved intraoperative hemostasis while maintaining comparable enucleation efficiency. Although POD1 hemoglobin values were higher with the 2.0 system, the difference was small and unlikely clinically meaningful. Secondary postoperative outcomes were also similar between groups. Our findings suggest that the primary advantage of the updated technology lies in enhanced hemostatic performance rather than procedural efficiency.